Enovis Corp
NYSE:ENOV
Enovis Corp
NYSE:ENOV
Price:
51.27 USD
-1.65%
Market Closed
Updated:
May 5, 2024
Enovis Corp
Revenue
|
Enovis Corp
Revenue Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Enovis Corp
NYSE:ENOV
|
Revenue
$1.7B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$21B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Enovis Corp
Revenue Breakdown
Breakdown by Geography
Enovis Corp
Enovis Corp
|
Total Revenue:
1.7B
USD
|
|
United States:
1.2B
USD
|
|
Foreign Locations:
554.8m
USD
|
Breakdown by Segments
Enovis Corp
Enovis Corp
|
Total Revenue:
1.7B
USD
|
|
Prevention And Recovery:
1.1B
USD
|
|
Reconstructive:
630.4m
USD
|
See Also
What is Enovis Corp's Revenue?
Revenue
1.7B
USD
1.7B
USD
Based on the financial report for Dec 31, 2023, Enovis Corp's Revenue amounts to 1.7B USD.
What is Enovis Corp's Revenue growth rate?
Revenue CAGR 5Y
-5%
-5%
Over the last year, the Revenue growth was 9%. The average annual Revenue growth rates for Enovis Corp have been -18% over the past three years , -5% over the past five years .
You don't have any saved screeners yet
